GLP1R and type 2 diabetes mellitus: The highly functionalized conjugate (average 106 Exendin‐4 molecules/γ‐Polyglutamic acid) showed affinity towards GLP1 receptor higher with respect to Enendin‐4 a labile peptide approved for type 2 diabetes treatment.